FAFCX
Price
$34.94
Change
-$0.47 (-1.33%)
Updated
Aug 15 closing price
Net Assets
683.93M
TFIFX
Price
$47.29
Change
-$0.63 (-1.31%)
Updated
Aug 15 closing price
Net Assets
2.08B
Interact to see
Advertisement

FAFCX vs TFIFX

Header iconFAFCX vs TFIFX Comparison
Open Charts FAFCX vs TFIFXBanner chart's image
Fidelity Advisor Financials C
Price$34.94
Change-$0.47 (-1.33%)
VolumeN/A
Net Assets683.93M
T. Rowe Price Financial Services I
Price$47.29
Change-$0.63 (-1.31%)
VolumeN/A
Net Assets2.08B
FAFCX vs TFIFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FAFCX vs. TFIFX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FAFCX is a Buy and TFIFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TFIFX has more cash in the bank: 2.08B vs. FAFCX (684M). TFIFX pays higher dividends than FAFCX: TFIFX (1.13) vs FAFCX (0.61). FAFCX was incepted earlier than TFIFX: FAFCX (28 years) vs TFIFX (9 years). FAFCX (1.75) is less costly to investors than TFIFX (0.79). TFIFX is a more actively managed with annual turnover of: 46.90 vs. FAFCX (44.00). FAFCX has a lower initial minimum investment than TFIFX: FAFCX (0) vs TFIFX (500000). FAFCX annual gain was more profitable for investors over the last year : 19.06 vs. TFIFX (17.77). TFIFX (114.08) and FAFCX (108.95) have equivalent 5 years return.
FAFCXTFIFXFAFCX / TFIFX
Total Expense Ratio1.750.78224%
Annual Report Gross Expense Ratio1.750.79222%
Fund Existence28 years9 years-
Gain YTD7.83911.21870%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets684M2.08B33%
Annual Yield % from dividends0.611.1354%
Returns for 1 year19.0617.77107%
Returns for 3 years38.8449.4978%
Returns for 5 years108.95114.0896%
Returns for 10 years136.56N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARQT16.890.91
+5.69%
Arcutis Biotherapeutics
DRMA5.980.17
+2.93%
Dermata Therapeutics Inc
CART43.920.04
+0.10%
Maplebear
ASRT0.81-0.01
-0.64%
Assertio Holdings
WNC10.67-0.15
-1.39%
Wabash National Corp